18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma

被引:2
作者
Suzuki, Shinsuke [1 ]
Toyoma, Satoshi [1 ]
Abe, Tomoe [1 ]
Endo, Tentaro [1 ]
Kouga, Teppei [1 ]
Kaswasaki, Yohei [1 ]
Yamada, Takechiyo [1 ]
机构
[1] Akita Univ, Dept Otorhinolaryngol & Head & Neck Surg, Grad Sch Med, Akita 0108543, Japan
关键词
Hypopharyngeal squamous cell carcinoma; Distant metastasis; 18F-FDG-PET/CT; Maximum standardized uptake value; Survival; METABOLIC TUMOR VOLUME; PROGNOSTIC VALUE; NECK-CANCER; FDG-PET; HEAD; SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY; CETUXIMAB; RECURRENT;
D O I
10.1186/s40463-022-00568-8
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Hypopharyngeal squamous cell carcinoma (HPSCC) has a high rate of distant metastasis, resulting in poor prognosis. The role of the maximum standardized uptake value (SUVmax), which was assessed via pretreatment 18-fluorodeoxyglucose positron emission tomography (FDG-PET), and computed tomography (CT) was examined, for predicting distant metastasis and survival. Methods: This study included 121 patients who underwent pretreatment FDG-PET/CT scanning and subsequent treatment for HPSCC. The SUVmax was measured via FDG-PET/CT. A receiver operating characteristic (ROC) curve analysis was used to determine whether the SUVmax was a predictor of distant metastasis and to select the best cutoff value. Univariate and multivariate Cox hazard regression analyses were used in identifying associations between the SUVmax and other clinicopathological factors with distant metastasis-free survival. Results: Distant metastases were identified in 33 patients during the median follow-up of 24 months after treatment. The ROC curve analysis determined that SUVmax was predictive of distant metastasis and identified a SUVmax of 13.9 as the best potential cutoff value. The univariate analysis showed that T and N classification, clinical stage, and SUVmax were significantly related to distant metastasis. However, in multivariate analysis, an SUVmax >= 13.9 was the only independent predictor of distant metastasis. Patients with high SUVmax values displayed significantly shorter distant metastasis-free survival and overall survival. Conclusions: SUVmax determined via pretreatment FDG-PET/CT is useful for predicting distant metastasis, distant metastasis-free survival, and overall survival in patients with HPSCC.
引用
收藏
页数:8
相关论文
共 26 条
  • [1] Bierley JD., 2017, UICC TNM Classification of Malignant Tumours. Digestive System Tumours, V8th
  • [2] Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
    Burtness, Barbara
    Harrington, Kevin J.
    Greil, Richard
    Soulieres, Denis
    Tahara, Makoto
    de Castro, Gilberto, Jr.
    Psyrri, Amanda
    Baste, Neus
    Neupane, Prakash
    Bratland, Ase
    Fuereder, Thorsten
    Hughes, Brett G. M.
    Mesia, Ricard
    Ngamphaiboon, Nuttapong
    Rordorf, Tamara
    Ishak, Wan Zamaniah Wan
    Hong, Ruey-Long
    Mendoza, Rene Gonzalez
    Roy, Ananya
    Zhang, Yayan
    Gumuscu, Burak
    Cheng, Jonathan D.
    Jin, Fan
    Rischin, Danny
    [J]. LANCET, 2019, 394 (10212) : 1915 - 1928
  • [3] Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy
    Castelli, J.
    De Bari, B.
    Depeursinge, A.
    Simon, A.
    Devillers, A.
    Jimenez, G. Roman
    Prior, J.
    Ozsahin, M.
    de Crevoisier, R.
    Bourhis, J.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 108 : 40 - 51
  • [4] Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review
    Creff, Gwenaelle
    Devillers, Anne
    Depeursinge, Adrien
    Palard-Novello, Xavier
    Acosta, Oscar
    Jegoux, Franck
    Castelli, Joel
    [J]. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2020, 146 (05) : 471 - 479
  • [5] SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancer
    Doi, Hiroshi
    Kitajima, Kazuhiro
    Fukushima, Kazuhito
    Kawanaka, Yusuke
    Mouri, Miya
    Yamamoto, Satoshi
    Ishikura, Reiichi
    Terada, Tomonori
    Noguchi, Kazuma
    Hirota, Shozo
    [J]. JAPANESE JOURNAL OF RADIOLOGY, 2016, 34 (05) : 349 - 355
  • [6] Distant metastases in head and neck cancer
    Duprez, Frederic
    Berwouts, Dieter
    De Neve, Wilfried
    Bonte, Katrien
    Boterberg, Tom
    Deron, Philippe
    Huvenne, Wouter
    Rottey, Sylvie
    Mareel, Marc
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (09): : 1733 - 1743
  • [7] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1856 - 1867
  • [8] Relationship Between Hematotoxicity and Serum Albumin Level in the Treatment of Head and Neck Cancers with Concurrent Chemoradiotherapy Using Cisplatin
    Ishizuka, Masako
    Fujimoto, Yasushi
    Itoh, Yoshiyuki
    Kitagawa, Koichi
    Sano, Motoki
    Miyagawa, Yasuhiro
    Ando, Atsushi
    Hiramatsu, Mariko
    Hirasawa, Naoki
    Ishihara, Shunichi
    Nakashima, Tsutomu
    Yamada, Kiyofumi
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 973 - 979
  • [9] METASTATIC PATTERNS IN SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    KOTWALL, C
    SAKO, K
    RAZACK, MS
    RAO, U
    BAKAMJIAN, V
    SHEDD, DP
    [J]. AMERICAN JOURNAL OF SURGERY, 1987, 154 (04) : 439 - 442
  • [10] Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial
    Krak, NC
    Boellaard, R
    Hoekstra, OS
    Twisk, JWR
    Hoekstra, CJ
    Lammertsma, AA
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (03) : 294 - 301